Optiver Holding
WVE icon

Optiver Holding’s Wave Life Sciences WVE Stock Holding History

Optiver Holding’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.79K Sell
308
-172
-36% -$1.14K ﹤0.01% 2341
2026
Q1 		$3.48K Buy
480
+222
+86% +$2.89K ﹤0.01% 1588
2025
Q4 		$4.39K Sell
258
-742
-74% -$7.54K ﹤0.01% 1464
2025
Q3 		$7.32K Buy
+1,000
New +$8.09K ﹤0.01% 1488

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Optiver Holding's WVE Position: Q2 2026 in Review

Optiver Holding reduced its Wave Life Sciences (WVE) stake by 36% in Q2 2026, selling an estimated $1.14K and leaving 308 shares worth $1.79K. The position accounts for ﹤0.01% of the portfolio, ranked #2341.

Optiver Holding first reported a position in WVE in Q3 2025 and has held it in 4 quarters since. The position peaked at $7.32K in Q3 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Optiver Holding held 308 shares of Wave Life Sciences worth $1.79K as of Q2 2026.
  • Optiver Holding sold 172 Wave Life Sciences shares in Q2 2026, an estimated $1.14K.
  • Wave Life Sciences made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #2341 holding.
  • Optiver Holding first reported a position in Wave Life Sciences in Q3 2025 and has held it in 4 quarters since.
  • Optiver Holding's Wave Life Sciences position peaked at $7.32K in Q3 2025.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.